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The spread of infections in healthcare environments is a persistent and growing problem in
most countries, aggravated by the development of microbial resistance to antibiotics and
disinfectants. In addition to indwelling medical devices (e.g. implants, catheters), such
infections may also result from adhesion of microbes either to external solidewater in-
terfaces such as shower caps, taps, drains, etc., or to external solidegas interfaces such as
door handles, clothes, curtains, computer keyboards, etc. The latter are the main focus of
the present work, where an overview of antimicrobial coatings for such applications is
presented. This review addresses well-established and novel methodologies, including
chemical and physical functional modification of surfaces to reduce microbial contami-
nation, as well as the potential risks associated with the implementation of such anti-
contamination measures. Different chemistry-based approaches are discussed, for
instance anti-adhesive surfaces (e.g. superhydrophobic, zwitterions), contact-killing sur-
faces (e.g. polymer brushes, phages), and biocide-releasing surfaces (e.g. triggered
release, quorum sensing-based systems). The review also assesses the impact of topo-
graphical modifications at distinct dimensions (micrometre and nanometre orders of
magnitude) and the importance of applying safe-by-design criteria (e.g. toxicity, contri-
bution for unwanted acquisition of antimicrobial resistance, long-term stability) when
developing and implementing antimicrobial surfaces.
ª 2018 The Author(s). Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).e do Porto Faculdade de
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Infections and infectious diseases are a continuous threat to
human health. According to the European Centre for Disease
Prevention and Control, more than four million people arehe Healthcare Infection Society. This is an open access article
nc-nd/4.0/).
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every year in Europe (1.7 million in the USA) [1]. The number of
deaths occurring as a direct consequence of these infections is
estimated to be at least 37,000, and these infections are
thought to contribute indirectly to an additional 110,000
deaths each year (in the USA, a total of 99,000 deaths is
estimated).
The present review does not deal with indwelling medical
devices. It is mostly focused on solideair interfaces in health-
care units, such as tables, door-handles, computer keyboards,
textiles, although solideliquid surfaces are also of great
concern in hospitals such as taps, showers and drains, where
biofilms appear frequently. New methods, in addition or as an
alternative to appropriate use of disinfectants and antibiotics,
are required to reduce microbial activity, associated infections
and to reverse the increase in antimicrobial resistance. A po-
tential and promising weapon against bacterial growth and
possibly the development of multidrug-resistant bacteria has
been found in antimicrobial (nano)coatings (AMC) [2,3].
A state-of-the-art innovation to combat pathogenic bacteria
is the creation of self-disinfecting surfaces through the appli-
cation of coatings with antibiofouling and/or bactericidal
properties. Bactericidal coatings are interesting in healthcare
because of the capability of these coatings to kill pathogens
upon contact. Many different chemical strategies and tech-
nologies for antibacterial coatings are described in the litera-
ture. For instance, antibacterial coatings may contain active
eluting agents (e.g. ions or nanoparticles of silver, copper,
zinc, or antibiotics, chloride, iodine), immobilized molecules
that become active upon contact (e.g. quaternary ammonium
polymers or peptides), or light-activated molecules (e.g. TiO2
or photosensitizers) [4e6].
In addition to chemical modifications, the topography of a
surface can by itself significantly affect its hygienic status,
either in a beneficial manner (reducing microbial retention) or
otherwise (increasing retention) [7]. As such, modifications of
surfaces to enhance antimicrobial properties should always
take into account the effect of surface wear on subsequent
fouling and cleanability. Therefore, efforts should be under-
taken to characterize typical wear, assess interactions with the
most likely micro-organisms in that environment, and define
the most appropriate and least damaging cleaning and sanitizer
regimes. The best way to achieve such outcomes is to ensure
that multidisciplinary expertise is integrated into develop-
mental processes, and that testing methods are appropriately
robust [8].
A relevant aspect of the surfaces is that they should be safe-
by-design (SbD). In a broad sense, SbD is the elimination of the
potential health and safety risks associated with a product or
process by taking into account those potential risks during the
early design phase. SbD is a generic concept with an ultimate
goal of obtaining a product that complies with all regulations by
designing out the health and safety risks that can be more
difficult or sometimes impossible to deal with in the long-term
after the market introduction. The SbD approach is not new in
industry and has been used for many years under different
names by the construction industry, aircraft industry, railway
industry, etc. [9]. This opinion paper starts by assessing the
different types of strategy to chemically modify the surfaces
and by identifying potentially new strategies, followed by
discussions on the impact of topography and the importance of
the SbD approach.Methods
Through its Cooperation in Science and Technology pro-
gramme (COST), the European Commission has recently funded
a four-year initiative to establish a network of stakeholders
involved in development, regulation, and use of novel anti-
microbial coatings for prevention of HCAI [10]. The network
AMiCI (AntiMicrobial Coating Innovations) currently comprises
participants of more than 60 universities, research institutes
and companies across 30 European countries (www.amici-
consortium.eu) and, to date, represents the most compre-
hensive grouping to target the use of these emergent tech-
nologies in healthcare settings. Within AMiCI, one of the
working groups is collecting information on commercially
available antimicrobial coatings with actual or potential
application in healthcare, and the development of new coat-
ings that are SbD. This review article is the result of extensive
discussion within the working group and the AMiCI consortium
as a whole, following the ‘world cafe´ approach’ [11].
For the identification of relevant publications, a literature
search was performed in SciFinder and PubMed of studies
published between 2000 and 2017. The following search terms
were used, coupled with the keywords ‘surface’ OR ‘coating’:
‘antimicrobial’, ‘antibacterial’, ’functionalized’, ‘safe-by-
design’, ‘topography AND (microorganism OR bacteria)’,
‘contact active’, ‘anti-adhesive’, and ‘biocide release’. Due
to the high number of studies identified, each of the publi-
cations was then assessed for its suitability and relevance of
the findings to the topic of the present review. A few publi-
cations that were not identified in the previous search, but
that were known to the authors as cornerstone studies in the
field of surface modifications in healthcare settings, were also
included.Chemical modifications to achieve functional
antimicrobial coatings
Strategies to achieve antimicrobial coatings can be classi-
fied according to their functional principle as: (i) anti-
adhesive, (ii) contact active, and (iii) biocide release
(Figure 1). Whereas the first two principles may be considered
as SbD, biocide release incorporates the release of a toxic
substance and can therefore be considered as toxic by design.
Sometimes two functional principles are combined to achieve
synergistic effects, e.g. by embedding biocidal substances into
anti-adhesive surfaces. Today, the majority of chemical mod-
ifications includes hydrogels or poly(ethylene glycol) (PEG) to
repel approaching microbes, metals (in particular, silver and
copper), antimicrobial peptides (AMPs), quaternary ammonium
compounds (QACs), and nanoparticles [13e18]. Beyond those
established approaches, state-of-the-art or potentially new
strategies towards antimicrobial coatings were identified at
the AMiCI meetings and were sorted and classified according to
their functional principle. For many of the latest antimicrobial
strategies, the mechanism of antimicrobial activity is still un-
der investigation and there is not enough information available
on whether antimicrobial activity happens directly at the sur-
face or whether small amounts of active compounds are
released into the test media where they will exert their anti-
microbial activity, or whether both mechanisms are acting in
parallel.
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Figure 1. Established (black) and potentially upcoming strategies
(blue) for antimicrobial coatings classified by their functional
principle. The functional principle is also a matter of imple-
mentation, e.g. QACs are active both chemically bound to a sur-
face and in solution. Results from the AMiCI meeting. Carbon
nanotubes (CNTs), graphene(oxide)s (GOs), poly(ethylene glycol)
(PEG) quaternary ammonium compounds (QACs), antimicrobial
proteins peptides (AMPs), nanoparticle (NP).
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Anti-adhesive surfaces can reduce the adhesion force be-
tween bacteria and a solid surface to enable the easy removal
of bacteria before a biofilm layer is formed on the surface [19].
Such surfaces may suppress HCAI by blocking transmission
paths involving surfaces, but they will not reduce the number
of germs on the contacting media by killing them. Attachment
of bacteria or cells starts with an initial adsorption of proteins
on to the material surface [20]. Strategies to prevent protein
attachment include superhydrophobic surfaces, often
augmented by a hierarchical nanostructure as well as zwit-
terionic polymers [19,21].
Superhydrophobic surfaces are characterized by a water
contact angle >150 and they are inspired by the lotus leaf in
nature [22]. It was further revealed that the lotus leaf has a
hierarchical micro/nanostructure [23]. Reducing bacterial
adhesion via superhydrophobicity is a relatively new topic and
has yet to be studied thoroughly and systematically [19].
Analysis of superhydrophobic siloxane and fluorosiloxane sur-
faces showed also minimal protein adsorption, both before and
after protein adsorption trials [24].
Nanostructures are important, since effective air entrap-
ment in the three-dimensional nanomorphology (nanopillars)
renders them superhydrophobic and slippery. On inherently
nanostructured hydrophilic aluminium, adhesion forces of
bacteria were reduced by a factor of 4 down to 2e4 nN
compared to the electropolished flat surface, resulting in an
88% reduction of colony-forming units (cfu) for Staphylococcus
aureus. This effect was even more pronounced after applying a
hydrophobic Teflon coating, yielding a 99.9% reduction under
flow conditions [25].Nanostructured surfaces were also prepared using electro-
spun polystyrene nanofibres. When oxygen plasma-treated, a
superhydrophilic surface was generated, which exhibited
limited Escherichia coli attachment due to negative zeta po-
tential of e40 mV. After fluorination, a superhydrophobic sur-
face was obtained, which exhibited self-cleaning ability
against bacteria, where the initially adhered bacteria were
effectively removed with subsequent washing [26]. Anti-
adhesion and killing was achieved by combining an upper
superhydrophobic surface layer (silane coated poly(acrylic
acid)) with limited bacterial adhesion and self-cleaning prop-
erties with a hydrophilic bottom layer (poly(ethyleneimine)e
Agþ complex) which could deliver bactericidal silver ions [27].
An interesting anti-adhesive and killing approach is found in
nature. The nanopatterned cicada wing surface uses an
adsorption and stretching mechanism with eventual rupture.
As the bacterial cells adsorb on to the nanopillared structures
present on the wing surfaces, the bacterial cell membrane
stretches in the regions suspended between the pillars. If the
degree of stretching is sufficient, cell rupture will occur [28].
Zwitterionic polymer brushes may also delay or even pre-
vent microbial attachment to a surface, since the hydration
layer surrounding the ionic surface prevents non-specific pro-
tein adsorption [21]. Using barnacle cement, a biological ad-
hesive from barnacles, and ‘click’ chemistry, poly(2-
(methacryloyloxy)ethyl trimethylammonium chloride) polymer
brushes were successfully attached to stainless steel and
antimicrobial properties were demonstrated [21]. Zwitterionic
polymer brushes cannot inactivate bacterial cells. Therefore,
synergistic anti-adhesion and bacterial inactivation was ach-
ieved by grafting zwitterionic poly(sulfobetaine methacrylate)
brushes with embedded biocidal silver nanoparticles [29]. The
importance of anti-adhesive properties for biofilm formation
was also demonstrated by measuring the adhesive forces on
brush-coated silicone rubber and uncoated silicon rubber. On
the brush-coated rubber, adhesion was so weak that the bac-
teria were no longer able to sense the surface and therefore
remained in their planktonic state, susceptible to antibiotics
rather than forming a protected biofilm [30].
Contact-active surfaces
Contact-active surfaces exhibit antimicrobial activity
without releasing biocidal substances. Several mechanisms are
believed to take place in contact-active surfaces [31]. These
are: (i) a so-called spacer effect, where the biocidal group is
attached to the surface through a polymer chain, allowing the
biocide to reach the cytoplasmic membrane of the bacteria and
to perforate them; (ii) alternatively, positively charged QACs,
e.g. 3-aminopropyl trimethoxysilane grafted to cellulose
nanofibres, can detach phospholipids from the cell membrane
and thereby kill the bacteria [32e34]. This approach is also
referred to as biomimetic with respect to the activity of chi-
tosan e a polysaccharide derived from exoskeleton of crusta-
ceans or cell walls of fungi. Hydrophobic parts of a surface can
act similarly to QACs by deforming the membrane through
adhesion [35].
Polymer brushes have been widely used in preparing
contact-active antimicrobial surfaces without biocidal release.
The rationale behind polymer brushes is the observation that
antimicrobial molecules lose much of their activity, once
attached to a surface. When providing an anchor for the active
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the active molecule should still be able to reach the site of
action at or within the bacterium, e.g. by penetrating its cell
wall, but leaching is still suppressed. Important parameters for
polymer brush anchors are chain length and chain density.
Polymer brushes have been shown to be effective for anchoring
QACs or AMPs [36e40]. Using surface-initiated atom transfer
radical polymerization, QACs with charge densities of
>1.5e1015 accessible quaternary amine units/cm2 were
anchored through poly-2-(dimethylamino)ethyl methacrylate
chains. Interestingly, these surfaces were bioactive even
though the polymer chains were too short to penetrate the
cells with envelope thicknesses of 46 nm for Gram-negative
E. coli and 45.55 nm for Gram-positive Bacillus subtilis [36].
This demonstrates that surface charge density can be more
important than chain length. On the other hand, it was clearly
shown that N-alkyl-pyridinium exhibited high antimicrobial
activity when anchored through a 750 or 25 kDa poly-
ethyleneimine (PEI) but showed no activity when using the
2 kDa analogue [37]. Therefore, only long-chained, moderately
hydrophobic immobilized polycations exhibit microbicidal ac-
tivity. Interestingly, polycationic polymer brushes are not
subject to existing mechanisms of resistance such as multidrug-
resistance pumps or multidrug tolerance protein-expressing
cells, presumably since there are no analogue structures in
nature [37].
Polymer brushes have also successfully been used for
anchoring AMPs. AMPs are a logical alternative to conventional
antibiotics due to their broad-spectrum antimicrobial activities
[38]. Surface concentrations of AMPs up to 5.9 mg/cm2 were
achieved by conjugating the peptides to surface-immobilized
primary amine functionalized polymer chains obtained by
aqueous surface-initiated atom transfer radical polymerization
of N,N-dimethylacrylamide and aminopropyl methacrylamide
hydrochloride [38]. The efficacy of AMPs attached to catheter
material surface using polymer brushes was verified in vivo by
using a catheter-associated urinary tract infection mouse
model [39]. By adding arginineeglycineeaspartate peptides to
promote host-tissue cell adhesion to AMPs anchored through
the block copolymer Pluronic F-127, two effects were ach-
ieved, namely thwarting bacteria from approaching and
attaching to the surface and, simultaneously, enhancing tissue
integration [40].
A completely different approach is given by immobilizing
bacteriophages on surfaces [41]. Bacteriophages are viruses
that infect bacteria and are highly efficient and relatively cost-
effective. Bacteriophages are host specific, but they can have a
broad host range, infecting several strains or species of bac-
teria, both Gram-positive and Gram-negative. They proved to
be efficient in preventing bacterial contamination and recently
they became accepted for food treatment to counter food
contamination during storage. In addition, the fact that the EU
is contributing V3.8 million to the Phagoburn study shows that
it is willing to consider the approach [42]. Attachment of
bacteriophages to a surface can be achieved through phys-
isorption, electrostatic attachment, and covalent bonding
[43]. Sample surfaces, which exhibited antimicrobial activities
with immobilized phages, included gold, glass, cellulose
membrane, and hydrogels [44e47]. Phages are specifically
sensitive to moisture and can be deactivated when dried.
However, reactivation upon wetting is feasible, and addition of
polysaccharides improves their stability [43].Two other groups of naturally occurring antimicrobials
are claimed as alternatives to antibiotics: bacterial cell wall
hydrolases (BCWHs) and antimicrobial peptides [48]. Anti-
microbial peptides have a broad-spectrum against bacteria and
fungus, low level of induced resistance, but may cause toxicity
at high doses in order to be efficient and are more costly to
produce. BCWHs have limitations towards Gram-negative
bacteria, due to the presence of the outer membrane, and
some important Gram-positive pathogens such as S. aureus are
already resistant to lysozymes.
Biocide-releasing surfaces
Biocide-releasing surfaces may have some conceptual dis-
advantages since they are toxic by design in terms of releasing
biocidal substances. In addition they will gradually become
inactive and they may induce the formation of resistance [31].
Catalytically active surfaces, such as photocatalytically active
surfaces (e.g. TiO2) which regenerate reactive oxygen species
upon UV radiation, provide an alternative.
Another approach is triggered release depending on certain
threshold concentrations of quorum-sensing molecules which
are found in biofilms [49,50].
Surface coating with carbon nanotubes (CNTs), graphene
or diamond-like carbons (DLCs) promised interesting anti-
microbial activity, since these materials show relatively low
cytotoxicity towardsmammalian cells.Whether thesematerials
are active on the surface or whether they achieve antimicrobial
activity through releasing traces into the aqueous phase is not
yet resolved, but their activity in microbial suspensions is
clearly demonstrated, e.g. higher toxicity is found for
surfactant-dispersed CNTs [51]. The most frequently proposed
mechanisms of action fall under four categories: (i) oxidative
stress induction, (ii) protein dysfunction, (iii) membrane
damage, and (iv) transcriptional arrest [52]. Recently, it was
also demonstrated that the mechanism of action depends on
the concentration of the bacteriocide e in this case graphene
oxide (GO): low GO concentrations cut membranes of the
micro-organisms S. aureus and E. coli whereas high concen-
trations induce the formation of GO aggregates shielding their
edges. When cluster size increases, bacterial deactivation
through wrapping is observed [53].
Graphene-based materials differ in their morphology (mono
and multilayers) as well as in their surface chemistry (gra-
phene, GO, reduced graphene oxide (rGO)). Lateral size for
instance is important to enhance bacterial adhesion whereas
the sharp edges may act as nanoknifes. GOs can enhance the
antimicrobial activity through oxidative stress with or without
the production of reactive oxygen species [54]. When
comparing the antibacterial activity of graphite, graphite ox-
ide, GO, and rGO towards E. coli under similar conditions, GO
showed the highest antibacterial activity, followed by rGO,
graphite, and graphite oxide [51]. Synergistic effects are re-
ported for graphene-based silver nanocomposites and com-
posites with other antibacterial nanoparticles, as well as with
polymeric or enzymatic bactericides [55].
Carbon nanotubes have also been widely studied as anti-
microbial material since they can be easily embedded into
polymers. Again, a variety of morphologies has been studied
such as single wall or multi-wall, but it seems that GO-based
materials show higher antimicrobial activity [56]. Synergistic
effects were obtained by making composites of CNTs and
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poly(amidoamine)dendrimer-immobilized CDs and Ag2S quan-
tum dots which enhanced the antimicrobial activity in solution
[57,58]. CNTs can also be used to prepare antimicrobial coat-
ings either by electrodeposition of a polyvinyl-N-carba-
zoleeCNT film or by preparing spin-coated films [59]. In the
same work, the antimicrobial activity of dispersed CNTs was
studied and it was found that such antimicrobial activity
depended on the degree of dispersions. Antimicrobial activity
of CNTs depends also on the length of CNTs, as was shown for
poly(lactic-co-glycolic acid)-embedded CNTs, where the
shorter ones were more active [60].
Diamond-like carbons represent a further morphology of
carbon materials. In contrast to graphite, graphene and CNTs,
tetrahedrally structured amorphous carbons with CeC sp3
bonding are dominating with a significant amount of CeH
bonds. They can be prepared by chemical vapour deposition,
e.g. on stainless steel surfaces, and they can be doped with
known antimicrobial metals such as copper, silver, or platinum
[61]. When comparing the antimicrobial activity of pure DLCs
and germanium-doped DLCs, significant reduction in Pseudo-
monas aeruginosa biofilm formation was observed whereas
these surface films showed no effect against Gram-positive
S. aureus biofilms [61].
Carbon quantum dots (CDs) are a relatively new class of
carbon materials which can be used for bacterial identification
due to their tunable photoluminescence properties. CDs
exhibit low toxicity and appreciable biocompatibility [62].
When decorating the surface of CDs with QACs or Ag NPs, it was
possible to selectively attach C-dots to Gram-positive bacteria
and to induce antimicrobial activity through the membrane-
disrupting mechanism [62,63].
Photocatalytic oxidation is a possible alternative strategy
for antimicrobial coatings in the hospital environment [64].
Due to the self-regenerating biocidal effect of the catalytically
released reactive oxygen species, such surfaces remain active
throughout their lifetime. Many of the reported surfaces
contain the photocatalyst TiO2, which generates highly active
OH-radicals in the presence of water, oxygen, and UV-A light.
These highly reactive OH-radicals are able to destroy bacteria
[65]. Current research is focusing on shifting the photocatalytic
activity of such coatings towards the visible light range, e.g. by
adding silver nanoparticles which can act through their surface
plasmon resonance effects, or molybdenum [66,67]. When
incorporating a combination of photosensitive dyes such as
Crystal Violet with the inherently antimicrobial ZnO nano-
particles into polymer surfaces, synergistic photocatalytic
antimicrobial activity was reported. The polymers exhibited
significant bacterial kills using typical white light sources of
hospital environments within 1 h against Gram-positive bac-
teria and within 6 h against Gram-negative bacteria [68]. By
combining a dye with Ag nanoparticles, bactericidal activity of
the Ag nanoparticles could be enhanced under white light
illumination. It is believed that the enhancement effect is due
to an increase in bactericidal activity through the triplet state
of the dye by biomolecular reaction rather than by enhance-
ment of the concentration of reactive oxygen species [69].
Surfaces decorated with metal oxide Lewis acids such as
MoO3 or WO3 have also shown a broad-band antimicrobial ac-
tivity [70]. Their mechanism of action is based on the in-situ
generation of H3O
þ ions through the reaction with moisture
from the air [71,72]. The resulting acidified surfaces have a pHof 4.5e5.5 and the H3O
þ ions are able to diffuse through the
cell membranes where they can distort the pH-equilibrium and
transport systems of the cell [72,73].
Reduced toxicity and prolonged durability of the anti-
microbial effect may also be achieved by the triggered release
of biocidal molecules. Recent strategies are based on quorum
sensing: quorum-sensing molecules (e.g. homoserine lactones
for Gram-negative bacteria) enable bacteria to detect the
presence of other bacteria and to communicate with them
[74]. The concentration of quorum-sensing molecules increases
with bacterial multiplication and at certain threshold concen-
trations the expression of many genes is affected, such as
genes encoding for adhesion or lipases, which are particularly
abundant at sites of infection [75,76]. By coupling the anti-
biotic ciprofloxacin through a lipase-sensitive homoserine
group on to the surface of a PEG model compound, a self-
regulating system was obtained [75]. Alternatively, anti-
quorum sensing enzymes could prevent bacteria from forming
biofilms by suppressing the quorum-sensing molecule concen-
tration below the threshold value [74].
Many plant extracts are well known for their antimicrobial
properties and much research is devoted to their application to
protect food from pathogens [77]. However, limited research
has been done on investigating their efficacy on surfaces of
healthcare units or on medical devices, such as tympanostomy
tubes [78]. It has been shown that a tea-tree oil coating may
induce zones of inhibition against MRSA after a two-day incu-
bation [79].Impact of topography on surface effectiveness
It is generally acknowledged that defects or design features
on any inert surface can retain soil and/or micro-organisms,
and therefore affect cleanability, disinfection, and hygienic
status of the surface. Implications in the clinical environment
in terms of cross-infection control, the choice of surface ma-
terial to be used, and the cleaning and sanitization protocols
are significant.
However, the assumption ‘the rougher the surface, theworse
the hygienic status’ is somewhat simplistic, although many
publications make this type of claim. Cells are easily removed
from ‘smooth’ surfaces, but they may be retained within fea-
tures approximating in size to that of the cells. In larger fea-
tures, the cells may again be relatively easily removed.
Typically, surface topography is measured by the Ra-value,
defined as ‘the average departure of the surface profile from a
center line’. Other parameters are also used, but the Ra-value is
the most popular in the microbiology literature. An Ra-value of
0.8 mm is often deemed indicative of a hygienic surface. In
profilometry, a trace is taken of the surface, typically perpen-
dicular to the lay of the surface features, using a probe. How-
ever, the probe will itself vary in size, depending on the method
used to assess topography, from solid stylus, through laser
scanning to the nanoscale tip of the atomic force microscope
(which generates Ra-values in nanometers). The resolution of
these different probes will affect the result obtained, although,
using standardized surfaces of different degrees of roughness,
the ranking (if not the absolute measurement) would likely be
the same irrespective of the method used. In addition, the
profilometer might reveal a two- or three-dimensional impres-
sion of the surface. If two-dimensional, then the overall picture
Bacteria
Bacteria
(a) (b)
Figure 2. (a) Micron-sized features may favour bacterial adhe-
sion, whereas (b) nano-sized features may create difficult topo-
graphic conditions for attachment.
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trace might indicate a scratch or a pit e the type as well as
degree of roughness may be important in terms of microbial
retention. Three-dimensional images are more valuable, for
example revealing very different topographies for surfaces with
comparable Ra-values.
Since the Ra-value is a statistical measure, then the actual
feature size, or the variation in feature size across a surface, is
not revealed. This may be important if features of the
dimension of microbial cells are present within larger features,
with macro-, micro- and nano-features each potentially having
different effects on the retention of cells on the surface.
Indeed, the previously mentioned ‘lotus effect’ reveals that a
hierarchical micro/nanostructure can significantly reduce
retention, enabling cells to ‘roll off’ the surface. The fabrica-
tion of surfaces with well-defined nano-topographies provides
a new avenue for the design of anti-adhesive/easily cleanable
(and therefore hygienic) surfaces e depending on the intended
environment of use [80,81].
The environment in which surfaces are placed will also
affect their hygienic status. At a flowing solideliquid interface,
cells will move across the surface, and may be retained in
features where they may replicate and form biofilms with
accompanying ‘streamers’ which may detach and contaminate
downstream [82]. This is a particular issue with joints in pipe-
work. However, on open surfaces, at a solideair interface, the
cells tend to be deposited on the surface through contact with
vectors such as food, fingers, equipment, or splashing [83]. In
this case, replication is less likely, since water availability is
low, and the survival of cells on these surfaces is key to
maintaining hygienic status [84]. Antimicrobial surfaces, and/
or surfaces which are hard or difficult to abrade, coupled with
effective cleaning regimes, are strategies employed to counter
this phenomenon. The continued cleaning/soiling cycle can
itself affect the surface, causing abrasions that result in
increased soiling and require increasing force in cleaning e
which in turn may increase abrasion. The nature of the surface
itself can affect how it wears: steel and other metals tend to
scratch; glass and ceramics tend to fracture; softer materials
such as plastics will abrade more easily.
Antimicrobial surfaces that actively leach out active agents
might prove more effective if the surface area is increased
through abrasion, but the presence of retained organic mater-
ial (blood, food, sputum) in addition to micro-organisms might
impede the antimicrobial effect and protect the microbial
cells. It might be argued that the increase in surface area
presented by surfaces with increased roughness is the driver for
the increased retention e but this has not been convincingly
proven. The features themselves, in terms of shape, profile,
and size clearly provide an increased area of contact for cells,
enhancing their ability to remain on surfaces [85]. All of these
issues should be considered when developing novel and effec-
tive antimicrobial surfaces, focusing on minimizing wear to
maintain cleanliness and cleanability.
At the cellular level, several studies focus on the retention of
cells on surfaces. The typical experiment involves the incubation
of surface with cell suspension for a specified time-period (such
as 1 h), rinsing and removal prior to staining retained cells, and
quantifying the amount of retention (cell numbers per unit area,
or area of microscopic field covered by cells). However, one
might debate which is more desirable: high numbers of retained
cells which are easily removed, in comparison to low numbers ofretained cells which resist detachment. Here, issues of cell sur-
vival and inactivation are also important.
The atomic force microscope is one means of assessing the
strength of attachment of cells on a surface. The probe scans
repeatedly across the surface, moving vertically in response to
surface features. This movement is captured and imaged using
lasers. By increasing the force of the scan, less strongly
attached cells are removed. Thus the strength of attachment
as well as the amount of retention can be assessed [85]. This
work has revealed that the size of cells and their relationship
with the feature size affect strength of attachment: as might
be expected, comparable feature size and cell size is the least
desirable combination, enabling maximum contact area be-
tween cell and surface. In addition, cell shape will also affect
this interaction, with rod-shaped cells having a larger area of
contact available for interaction with the cell surface in com-
parison to cocci. Investigation of the strength of attachment of
cells on linear features where the force is applied either across
or along the feature has revealed different results: demon-
strating easier removal along well-defined features on
titanium-coated stainless steel, but easier removal by applying
force across features on softer polymeric surfaces [86,87]. As
noted above, this work has led to the fabrication of surfaces
with designed topographies that are targeted at inhibiting
attachment of particular cells, where surface features smaller
than cells might reduce their ability to strongly attach to the
surface, and therefore improve cleanability (Figure 2). The
robustness of these surfaces is essential to ensuring a long-
lasting effect, and the potentially interfering effect of
organic material must also be considered.
When considering open surfaces that are usually present at
a solideair interface, which is the main focus of this paper,
biofilms are of less concern. In the clinical/medical environ-
ment, high-touch surfaces (worktops, walls, door-handles,
telephones, patient surrounds) are the prime focus for anti-
microbial treatments and/or effective cleaning. Solideliquid
interfaces, where biofilms could form, would likely be
encountered around taps, showers or drains. The topography of
the surface underlying the biofilm does not necessarily influ-
ence the quantity of the biofilm itselfe again depending on the
scale of feature size e but after cleaning, the substratum will
retain cells in features which can regrow and reduce the time
taken for the biofilm to develop once more.
Importance of safe-by-design in antimicrobial
coatings
Application of the SbD approach for AMCs that are based on
chemicals and nanomaterials is more challenging compared to
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neither standard test protocols nor enough data on the toxicity,
absorption, metabolism, excretion, accumulation and bio-
persistence of these antimicrobial agents (especially of the
nanomaterials), nor on their penetration into biological bar-
riers both at an environmental level and mammalian cell level.
EU programmes such as NanoFase, SafeNano, ProSafe, NaNo-
Reg, and Euro-NanoTox aim to allow the early assessment of
the toxicity and fate of nanomaterials with a strategy to
establish and implement standardized toxicological measure-
ment, establish international standards and to provide
centralized nanotoxicology information (Figure 3).
There are four main challenges in designing safe AMCs: (i)
the toxicity of the materials used; (ii) the potential impact of
the antimicrobial agent on the development of antimicrobial
resistance; (iii) the durability of the antimicrobial activity in
the long term (the long-term stability); (iv) the lack of stan-
dardized methods for testing the performance of the AMCs
under representative environmental conditions, namely their
antimicrobial efficacy and long-term stability.
Silver is the dominant type of antimicrobial agent used in
AMCs, followed by zinc oxide, zirconium, zinc omadine, tita-
nium dioxide, quaternary ammonia compounds. The current
AMC market mainly relies on the antimicrobial metal nano-
particles. Therefore, when talking about the toxicity of AMCs,
metallic nanoparticles e mainly nano-silver e are the main
subject. The environmental persistence and toxicity of bio-
cides and antimicrobial nanomaterials represent a potential
health and environmental issue. This may create a dilemma in
the attempt to control HCAI through antimicrobial strategies.
Because these antimicrobial strategies are employed to kill/
control bacteria while they pose the risk of spreading, assess-
ment is required for less known, less traceable and controllable
nanoparticles with hardly understood mechanisms of action,
toxicity and fate in the environment as well as within the body.
One of the goals of the AMiCI group is to join forces to tackle
such issues.In-vivo
Long-term /
acute / immuno-
toxicology;
mutogenicity; allergenicity
In-vitro and ex-vivo
Immunotoxicology; genotoxicology;
xenobiotic clearance; NP-degradation
Cellular exposure
Penetration / permeation; cytotoxicology 
In-vitro
Sample pre-evaluation; physico-chemical
characterization; hemotoxicology, cytotoxicology;
immunogenic and inflammatory potency
Risk assessment
Literature search and formulation of testing strategy
Figure 3. Multi-level Euro-NanoTox strategy. NP, nanoparticle.
Adapted from Falk [12].Mankind discovered the existence of one-celled microscopic
creatures in the 1670s following the studies of Leeuwenhoek.
Then it took almost 260 years to discover the first antibiotic for
the control of bacteria, but much longer to develop techniques
for the detection, monitoring and identification of bacteria in
various environments. We are now equipped with advanced
technology tools that enable us to detect and identify bacteria
in minutes or even in seconds with ‘standardized methods’, as
well as with many antibacterial agents effective in killing and
controlling bacteria. However, it is hard to say that the human
race won the fight against bacteria, as it is obvious that many of
the agents discovered and used against bacteria resulted in the
evolution of bacteria into much more resistant forms. Experts in
this field and the Centers for Disease Control and Prevention
define this problem as a ‘nightmare’ and an ‘apocalyptic threat’
for the human race. Although, shortly after his discovery of
penicillin in 1928, Alexander Fleming warned about the devel-
opment of antimicrobial resistance, it was not until the 2000s
that outcomes of antibiotic resistance were clearly understood
and large-scale official actions have been started. The difficulty
in preventing the spread of antibiotic resistance stems from the
widespread dissemination of antibiotics, and thus antibiotic
resistance develops in a wide range of environments including
hospitals, agriculture and food, community, soil, water re-
sources and associated sites. Therefore, the development and
implementation of SbD strategies is a key issue for the devel-
opment of future generations of coatings for healthcare envir-
onments, such as nano-antimicrobial-based AMCs. An important
requisite of AMCs is thus to minimize the risk of development of
another ‘apocalyptic threat’ due to the spread of biocides and
antimicrobial nanomaterials and the potential development of
associated antimicrobial resistance and other toxicity issues
while trying to control and prevent HCAI. Taking into account
our current ability to detect, identify and monitor the nano-
particles and to extend our knowledge on the mechanisms of
action, toxicity and fate of these nanoparticles in various envir-
onments, this might end up with a worst scenario.
An in-depth analysis of the toxicity and persistence of nano-
antimicrobials in the environment is necessary to assess the
safety of AMCs within the context of SbD. The rationale behind
adding an antimicrobial agent to a specific surface should be
balance between the potential impact of the antimicrobial
agent on the emergence of resistant microbial strains and the
impact of preventing the spread of the pathogenic microbial
strains within the healthcare environment, and thus on the
control of HCAI [88]. Several strategies have been employed to
produce SbD reduced toxicity antimicrobial nanomaterials
[89,90]. It is found that the concentration of nanoparticles to
which the cells are exposed, the type of surface coating, the
nature and extent of doping, and the aspect ratio of the par-
ticles make significant contributions to the cell toxicity of the
nanoparticles [91]. Recent studies showed that Fe-doping is a
possible safe design strategy for preventing ZnO toxicity in
animals and the environment [92,93]. Moreover, polymer
coating and modification with poly ethylene glycol (PEG) re-
duces the toxicity and cellular uptake of silver nanoparticles
(Ag NPs) [94].
The time and cost constraints of the toxicity assessment
methods represent another challenge for toxicity assessment
of the nano-antimicrobials used in AMCs. Predictive nano-
toxicology models appear as a feasible alternative for toxicity
assessment [95].
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microbial resistance is a challenge that should be taken into
serious consideration. Although the prevalence is still low,
silver-resistant bacterial strains were found in hospital sewage
systems [96]. Studies revealed the risk of both co- and cross-
resistance to antibiotics and antimicrobials used in AMCs (bio-
cides and metals) [97,98]. Therefore, these metal-based anti-
microbials might contribute to the maintenance and spread of
antibiotic resistance factors. Su¨tterlin et al. reported that sil-
ver resistance genes are widely represented in clinical isolates
of the genera Enterobacter and Klebsiella in Swedish health-
care facilities [99]. Therefore, to avoid further selection and
spread of silver-resistant bacteria with high potential for
healthcare-associated infections, the use of silver-based
products needs to be controlled and the silver resistance
monitored.
Antimicrobial efficacy and long-term stability against the
standard hygiene and sanitation protocols implemented in
healthcare facilities are the main performance criteria for the
AMCs aimed at reducing HCAI in healthcare facilities. Failure or
weakness in the rigorous assessment of the coatings may result
in unreliable performance. The lack of standard protocols for
assessing the antimicrobial efficacy and long-term stability of
the AMCs represents another challenge, which makes it impos-
sible to establish a proper comparison between AMCs with
different antimicrobial agents and processing technologies that
are both in the market and in the R&D phase. In fact, issues with
demonstration of functionality, efficacy, toxicity and potential
risk of antimicrobial resistance development are one of themain
market restraints for the commercialization of AMCs [10].Conclusions
As mentioned above, an effective antimicrobial coating
must achieve a multitude of characteristics: (i) be able to
control the pathogenic population of a surface; (ii) be stable
(mechanically, tribologically and chemically) in the wide range
of hospital settings; (iii) minimize (eco)toxicological hazards
and risks of antimicrobial resistance emergence; (iv) be
affordable and easily implemented. Future technological de-
velopments should hence aim at tackling most, if not all, of
these points. The ultimate goal of the antimicrobial coating,
namely the prevention of thousands of deaths occurring as a
direct consequence of HCAI in healthcare facilities, cannot be
tackled by the coating alone. But a tremendous common effort
involving coating technology providers, clinical and cleaning
staff as well as the responsible handling of antibiotics e to
name merely the clinical and agricultural sectors among many
others e is required.
Regarding the ability to control the pathogenic population
of a surface, very promising strategies have emerged. One of
these is widely known as selective killing, or the ability of
antimicrobial surfaces to target only those species that are
deemed to cause a risk to patients or hospital staff. Strategies
such as the use of quorum sensing at a threshold concentration
to release an antimicrobial compound have recently appeared.
Others, such as the modulation of the colonization consortia as
a whole to inhibit the dominance of pathogens, in a strategy
similar to the one used to control the human microbiome,
should start appearing as microbial ecological concepts are
better deciphered.Depending on their intended use, antimicrobial surfaces will
be challenged by a number of factors. For instance, door
handles are in intermittent contact with hands, but nonethe-
less are not expected to be exposed to as much wear as bed
linens, that should be washed on a daily basis. Studies on the
weariness or robustness of the different materials under
different conditions are available, but they require further
methodological standardization to allow for a more meaningful
interpretation of the results.
Biocidal chemicals used in antimicrobial coatings are
inherently toxic; biocide-releasing surfaces are subjected to
the Biocidal Products Regulation (BPR, Regulation (EU) 528/
2012) and by the Regulation (EC) No. 1907/2006 of the Euro-
pean Parliament and of the Council on the Registration, Eval-
uation, Authorization and Restriction of Chemicals (REACH).
This regulatory barrier makes it very expensive and time-
consuming to bring antimicrobial coatings, of which the anti-
microbial activity is related to biocidal release, to the market.
On the other hand, anti-adhesive surfaces can be considered as
SbD since there are no biocidal molecules involved which may
either induce toxic effects or lead to the evolution of resis-
tance. In this respect, the control of specific surface topog-
raphy characteristics, in conjugation with chemically based
strategies and specific cleaning protocols, could lead to a novel
generation of improved SbD products.
Overall, the novel strategies that are continuously being
developed in the area of nanosurfaces bring some hope to the
field of antimicrobial control, while decreasing microbial
resistance to antibiotics and associated infections in clinical
settings. It is then crucial to provide suitable standardized
assessment tests and a fast transition of these strategies from
the lab bench to the market, by conjugating efforts between
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